We found that the levels of CD3+ T, CD4+T, and CD4+/CD8+ in the peripheral blood of patients with colorectal cancer were significantly lower than those in the control group, while the level of CD8+T was significantly higher, indicating that the cellular immune function of patients with colorectal cancer was inhibited, which was basically consistent with previous reports [27]. This evidence concerns the gene CD4 and colorectal cancer.